Cargando…
P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429684/ http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13 |
_version_ | 1784779535204483072 |
---|---|
author | Wang, L. Xu, H. Liang, J. Li, Y. Shi, L. Xiao, B. Huang, J. Xu, X. Zhang, X. |
author_facet | Wang, L. Xu, H. Liang, J. Li, Y. Shi, L. Xiao, B. Huang, J. Xu, X. Zhang, X. |
author_sort | Wang, L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9429684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94296842022-08-31 P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA Wang, L. Xu, H. Liang, J. Li, Y. Shi, L. Xiao, B. Huang, J. Xu, X. Zhang, X. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429684/ http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Wang, L. Xu, H. Liang, J. Li, Y. Shi, L. Xiao, B. Huang, J. Xu, X. Zhang, X. P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA |
title | P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA |
title_full | P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA |
title_fullStr | P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA |
title_full_unstemmed | P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA |
title_short | P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA |
title_sort | p1465: initial safety and efficacy study of rm-001, autologous hbg1/2 promoter-modified cd34+ hematopoietic stem and progenitor cells, in transfusion-dependent βeta-thalassemia |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429684/ http://dx.doi.org/10.1097/01.HS9.0000848716.65161.13 |
work_keys_str_mv | AT wangl p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT xuh p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT liangj p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT liy p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT shil p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT xiaob p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT huangj p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT xux p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia AT zhangx p1465initialsafetyandefficacystudyofrm001autologoushbg12promotermodifiedcd34hematopoieticstemandprogenitorcellsintransfusiondependentbetathalassemia |